Author: KEI Staff

World Health Organization (WHO) to hold consultation on report of Expert Working Group on R&D financing

Posted on by KEI Staff

At the end of a dramatic debate that began yesterday, the Executive Board (EB) of the World Health Organization (WHO) agreed to hold a special consultation on the report of the WHO Expert Working Group (EWG) on R&D Financing. A face-to-face meeting will be held on May 13, a few days before the 63rd WHA begins on 17 May. There will also be opportunities for web submissions on the EWG report. In addition, Dr. Continue Reading →

Uncategorized

KEI Statement at SCCR 18, May 27, 2009

Posted on by KEI Staff

Congratulations on your record setting re-election as chairman of the SCCR, and for your excellent guidance this week.

With regard to the draft questionnaire, KEI suggests it be expanded to address exceptions found in Article 44 of the TRIPS, regarding alternatives to injunctions.

KEI supports the proposal by Brazil, Ecuador and Paraguay for a treaty for reading disabled persons, which is correctly inclusive in terms of disabilities covered.

Continue Reading →

Daily Calendar for Ambassador Ron Kirk, March 20 to May 1, 2009

Posted on by KEI Staff

Using the U.S. Freedom of Information Act (FOIA), KEI has obtained the daily schedule of Ambassador Kirk, from March 20 to May 1, 2009. KEI has separately asked the USTR to routinely as a matter of transparency post this information on the USTR web page.

The response to the follow is presented below in two pdf files:
March 20 to April 14, 2009
April 15 to May 1, 2009

Continue Reading →

Uncategorized

KEI Letter to Thailand Prime Minister and Health Minister, regarding compulsory licensing decisions

Posted on by KEI Staff

His Excellency Mr. Samak Sundaravej Prime Minister Government House Nakornpratom Rd. Dusit, Bangkok Thailand 10300 His Excellency Mr. Chaiya Sasomsap Minister of Public Health Tiwanont Rd. Talad Kwan District Nontaburi Province 11000 Thailand March 4, 2008 Re: Thailand Compulsory Licenses… Continue Reading →

Notes from March 16th 2007 U.S. Capitol Briefing on Thailand’s Compulsory Licenses

Posted on by KEI Staff

On Friday, March 16, KEI organized a briefing in the U.S. Capitol on Thailand’s recent compulsory licenses on three drugs; two for HIV/AIDS (Merck’s efavirenz (Stocrin) and Abbott’s lopinavir + ritonavir (Kaletra)) and one for heart disease (Sanofi’s clopidogrel (Plavix)). … Continue Reading →

European Commission Response to CPTech Letter Regarding EU Opt-out of WTO Compulsory Licensing Mechanism

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/wto/p6/eu12052005.pdf Letter from CPTech referenced available here: https://www.keionline.org/32641 MARKOS KYPRIANOU                                            PETER MANDELSON Member of the European Commission … Continue Reading →

Christine LAGARDE asked to change EU “opt-out” of 30 August 2003 decision regarding imports of generic medicines manufactured under a compulsory license

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/health/tamiflu/christinelagarde.html Christine LAGARDE asked to change EU “opt-out” of 30 August 2003 decision regarding imports of generic medicines manufactured under a compulsory license To: Christine LAGARDE, Ministre déléguée au Commerce extérieur, France From: Manon Ress and James Love,… Continue Reading →

CPTech Letter to EC Director General of Trade Peter Mandelson

Posted on by KEI Staff

Original page: http://www.cptech.org/ip/health/tamiflu/cptech-mandelson10192005.html CPTech Letter to EC Director General of Trade Peter Mandelson 19th October 2005 Commissioner Mandelson EUROPEAN COMMISSION DG Trade 200 rue de la Loi B-1049 BRUSSELS Dear Commissioner Mandelson TRIPS Agreement and Avian Influenza We ask the… Continue Reading →